Seoulin Bioscience Revenue

In the year 2024, Seoulin Bioscience had annual revenue of 75.41B KRW, down -15.81%. Seoulin Bioscience had revenue of 19.61B in the quarter ending December 31, 2024, a decrease of -25.42%.

Revenue

75.41B

Revenue Growth

-15.81%

P/S Ratio

0.75

Revenue / Employee

725.10M

Employees

104

Market Cap

54.92B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	75.41B	-14.16B	-15.81%
Dec 31, 2023	89.57B	-15.14B	-14.46%
Dec 31, 2022	104.71B	24.17B	30.01%
Dec 31, 2021	80.54B	15.45B	23.74%
Dec 31, 2020	65.09B	10.68B	19.62%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Electronics	300.87T
SK hynix	66.19T
LG Energy Solution	25.62T
Samsung Biologics	4,547.32B
Hyundai Motor Company	175.23T
Celltrion	3,557.30B
Kia Corporation	107.45T
KB Financial Group	15.01T

Revenue Rankings